Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
Cryoport (NASDAQ: CYRX) and Gulf Coast Regional Blood Center (GCRBC) have announced a strategic alliance to enhance cellular therapy services. This partnership coincides with the grand opening of Cryoport's IntegriCell™ Houston facility. The collaboration combines GCRBC's Cellular Life Solutions program, specializing in allogeneic donor recruitment and apheresis collection, with Cryoport's cryopreservation and biologistics expertise.
The alliance aims to enhance the availability of high-quality, manufacture-ready cryopreserved allogeneic leukopaks for cellular therapy research, development, and treatment. GCRBC's program is located less than two miles from Cryoport's Houston campus, enabling efficient local transport through Cryoport's Cryoshuttle® service. This partnership is expected to create a comprehensive and unified service offering for the life sciences community, streamlining processes and accelerating the development of cell therapies.
Cryoport (NASDAQ: CYRX) e il Gulf Coast Regional Blood Center (GCRBC) hanno annunciato un alleanza strategica per migliorare i servizi di terapia cellulare. Questa partnership coincide con il grande apertura della struttura IntegriCell™ di Cryoport a Houston. La collaborazione unisce il programma Cellular Life Solutions di GCRBC, specializzato nel reclutamento di donatori allogenici e nella raccolta di aferesi, con l'esperienza di Cryoport nella crioconservazione e nella biologistica.
L'alleanza mira a migliorare la disponibilità di leukopack crioconservati allogenici di alta qualità, pronti per la produzione per la ricerca, lo sviluppo e il trattamento nella terapia cellulare. Il programma di GCRBC si trova a meno di due miglia dal campus di Cryoport a Houston, consentendo un trasporto locale efficiente attraverso il servizio Cryoshuttle® di Cryoport. Si prevede che questa partnership crei un'offerta di servizi completa e unificata per la comunità delle scienze della vita, semplificando i processi e accelerando lo sviluppo delle terapie cellulari.
Cryoport (NASDAQ: CYRX) y el Gulf Coast Regional Blood Center (GCRBC) han anunciado una alianza estratégica para mejorar los servicios de terapia celular. Esta asociación coincide con la gran apertura de la instalación IntegriCell™ de Cryoport en Houston. La colaboración combina el programa Cellular Life Solutions de GCRBC, especializado en el reclutamiento de donantes alogénicos y la colecta por aferesis, con la experiencia de Cryoport en criopreservación y biologística.
La alianza tiene como objetivo mejorar la disponibilidad de leukopacks alogénicos criopreservados de alta calidad, listos para la fabricación para la investigación, el desarrollo y el tratamiento de terapias celulares. El programa de GCRBC se encuentra a menos de dos millas del campus de Cryoport en Houston, lo que permite un transporte local eficiente a través del servicio Cryoshuttle® de Cryoport. Se espera que esta asociación cree una oferta de servicios integral y unificada para la comunidad de ciencias de la vida, agilizando los procesos y acelerando el desarrollo de terapias celulares.
Cryoport (NASDAQ: CYRX)와 Gulf Coast Regional Blood Center (GCRBC)는 세포 치료 서비스를 향상시키기 위한 전략적 제휴를 발표했습니다. 이 파트너십은 Cryoport의 IntegriCell™ 휴스턴 시설의 대규모 개관과 동시에 이루어집니다. 이 협력은 GCRBC의 Allogeneic Life Solutions 프로그램, 즉 동종 기증자 모집과 아세시스 수집 전문 프로그램과 Cryoport의 cryopreservation 및 biologistics 전문성을 결합합니다.
이 제휴의 목표는 세포 치료 연구, 개발 및 치료를 위한 고품질 제조 준비가 완료된 동종 leukopak의 가용성을 향상시키는 것입니다. GCRBC의 프로그램은 Cryoport의 휴스턴 캠퍼스에서 2마일도 채 되지 않는 거리로, Cryoport의 Cryoshuttle® 서비스를 통한 효율적인 지역 운송이 가능합니다. 이 파트너십은 생명 과학 커뮤니티를 위한 포괄적이고 통합된 서비스 제공을 생성하고, 프로세스를 간소화하며 세포 치료 개발을 가속화할 것으로 기대됩니다.
Cryoport (NASDAQ: CYRX) et le Gulf Coast Regional Blood Center (GCRBC) ont annoncé une alliance stratégique pour améliorer les services de thérapie cellulaire. Ce partenariat coïncide avec la grande ouverture de l'installation IntegriCell™ de Cryoport à Houston. La collaboration combine le programme Cellular Life Solutions de GCRBC, spécialisé dans le recrutement de donneurs allogéniques et la collecte par aphérèse, avec l'expertise de Cryoport en cryoconservation et en biologistique.
Cette alliance vise à améliorer la disponibilité de leukopaks allogéniques cryoconservés de haute qualité, prêts à être fabriqués pour la recherche, le développement et le traitement en thérapie cellulaire. Le programme de GCRBC est situé à moins de deux miles du campus de Cryoport à Houston, permettant un transport local efficace grâce au service Cryoshuttle® de Cryoport. Ce partenariat devrait créer une offre de services complète et unifiée pour la communauté des sciences de la vie, rationalisant les processus et accélérant le développement des thérapies cellulaires.
Cryoport (NASDAQ: CYRX) und das Gulf Coast Regional Blood Center (GCRBC) haben eine strategische Allianz zur Verbesserung der Zelltherapiedienste angekündigt. Diese Partnerschaft fällt mit der großen Eröffnung der IntegriCell™-Einrichtung von Cryoport in Houston zusammen. Die Zusammenarbeit kombiniert das Programm Cellular Life Solutions von GCRBC, das sich auf die Rekrutierung von allogenen Spendern und die Apherese-Sammlung spezialisiert, mit Cryoports Fachwissen in den Bereichen Kryokonservierung und Biologistik.
Die Allianz zielt darauf ab, die Verfügbarkeit von hochwertig vorbereiteten Kryokonservierten allogenen Leukopaks für die Forschung, Entwicklung und Behandlung in der Zelltherapie zu erhöhen. Das Programm von GCRBC befindet sich weniger als zwei Meilen vom Cryoport-Campus in Houston entfernt, was einen effizienten lokalen Transport durch den Cryoshuttle®-Service von Cryoport ermöglicht. Es wird erwartet, dass diese Partnerschaft ein umfassendes und integriertes Dienstleistungsangebot für die Gemeinschaft der Lebenswissenschaften schafft, Prozesse optimiert und die Entwicklung von Zelltherapien beschleunigt.
- Strategic alliance formed between Cryoport and Gulf Coast Regional Blood Center to enhance cellular therapy services
- Grand opening of Cryoport's new state-of-the-art IntegriCell™ facility in Houston
- Collaboration aims to improve availability of high-quality cryopreserved allogeneic leukopaks for cellular therapy
- Streamlined process created for efficient local transport of collected leukopaks
- None.
Insights
This strategic alliance between Cryoport and Gulf Coast Regional Blood Center represents a significant development in the cellular therapy supply chain. By combining GCRBC's donor recruitment and collection capabilities with Cryoport's cryopreservation expertise, the partnership addresses a critical need in the industry for high-quality, readily available cellular materials.
The new IntegriCell™ facility in Houston creates a centralized hub for cellular therapy logistics, potentially reducing time and costs in the development and delivery of cell therapies. This could accelerate research and clinical trials, ultimately benefiting patients awaiting new treatments.
For Cryoport, this alliance expands its service offerings and strengthens its position in the cellular therapy market. The company's integrated approach, from collection to cryopreservation and logistics, could attract more biotech clients and potentially increase revenue streams. However, the impact on immediate financials may be as the cellular therapy field is still evolving.
Investors should monitor how this partnership translates into new client acquisitions and revenue growth for Cryoport in the coming quarters. The success of this alliance could set a precedent for similar collaborations in other regions, potentially expanding Cryoport's market reach.
Partnership Coincides with the Grand Opening of Cryoport's State-Of-The-Art IntegriCell™ Houston Facility
The launch of this partnership coincides with the grand opening of Cryoport's new state-of-the-art IntegriCell™ facility located at Cryoport's integrated supply chain campus in
This collaboration brings together GCRBC's Cellular Life Solutions ("CLS") program, which specializes in allogeneic donor recruitment, management, and apheresis collection, with Cryoport's industry-leading cryopreservation and biologistics expertise, creating a comprehensive and unified service offering for the life sciences community. GCRBC's CLS program is located less than two miles from Cryoport's
"Our partnership with Cryoport allows us to expand the capabilities of our Cellular Life Solutions program and further support the critical work being done with cell and gene therapies," said Nikhil Nayak, President and CEO of Gulf Coast Regional Blood Center. "Together, we are creating a streamlined process that strengthens the quality and consistency of cellular therapy products, ultimately accelerating the development of lifesaving treatments for patients."
"By working together with Gulf Coast Regional Blood Center, we are expanding the reach and impact of our cryopreservation services," said Jerrell Shelton, CEO of Cryoport. "This alliance enhances our ability to support the advancement and commercialization of cell therapies by providing the infrastructure for seamless, end-to-end delivery of critical cellular materials. Together, we are helping solve an industry problem and advance the development of the next generation of lifesaving cell therapies."
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMO's), contract research organizations (CRO's), developers, and researchers to carry out their respective business with products and services that are designed to derisk services and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are "Enabling the Future of Medicine™" worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.
Our corporate headquarters, located in
For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at www.twitter.com/cryoport for live updates.
About Gulf Coast Regional Blood Center
Gulf Coast Regional Blood Center (GCRBC) is one of the largest community blood centers in
For more information, visit www.giveblood.org. Follow via LinkedIn at https://www.linkedin.com/company/gulf-coast-regional-blood-center
Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to Cryoport's expectations about future benefits of the support GCRBC's Cellular Life Solutions (CLS) program, including the potential impact on future revenue and revenue streams. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-and-gulf-coast-regional-blood-center-launch-strategic-alliance-to-enhance-cellular-therapy-services-302282921.html
SOURCE Cryoport, Inc.
FAQ
What is the purpose of the strategic alliance between Cryoport and Gulf Coast Regional Blood Center?
What new facility did Cryoport open in Houston, Texas?
How does the proximity of GCRBC's Cellular Life Solutions program to Cryoport's Houston campus benefit the alliance?
What is Cryoport's stock symbol on NASDAQ?
